In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report), with a ...

Spatial transcriptomics was named the method of the year in 2020 (Nature 2021). Spatial transcriptomics has rapidly emerged ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Plans to Advance Iopofosine I 131 Internally, Through Strategic Partnerships and Other Approaches; Finalizing Confirmatory Study and Pathway for US FDA Accelerated Approval and EMA Prime Marketing ...

Geode Capital Management LLC acquired a new position in shares of MBX Biosciences, Inc. (NYSE:MBX – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund acquired 22,269 shares of the ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, ...

In a report released on January 10, Gena Wang from Barclays maintained a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report), with ...

QIAGEN N.V. today announced a new plan to return up to approximately $300 million (maximum EUR 281 million) to shareholders through a synthetic share repurchase that combines a direct capital ...

Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

The mining industry is undergoing a profound transformation, driven by advancements in precision technology and innovative approaches to tailings management. These advancements are not just ...

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...